BulkGLP Launches Multiple Retatrutide Vial Sizes 10mg 15mg 20mg 30mg to Meet Growing US Research Demand
United States, 27th Aug 2025 – BulkGLP, a Dallas-based supplier of high-purity research peptides, announced today the launch of multiple vial sizes of Retatrutide vials (10mg, 15mg, 20mg, 30mg), expanding availability to meet increasing demand among U.S. academic, clinical, and…